NOSU
NOTICE OF SUIT
05/26/2026
Back to search
Official data from USPTO
GLIOBLASTOMA FOUNDATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GLIOBLASTOMA FOUNDATION
ST13
US500000090683181Class
36
Filing
90683181
Registration
6933147
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
05/27/2026
Trademark type
Word
Nice classes
36
Filing date
04/30/2021
Registration date
12/27/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/27/2022
Last transaction
05/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/01/2016
First use in commerce
06/01/2016
Drawing code
4
Owner type
99
Owner location
Durham, NC, US
Examiner
YARD, JOHN S
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Glioblastoma Foundation, Inc.
Representatives
Naresh Kilaru FINNEGAN, HENDERSON, FARABOW, GARRETT &
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Accepting and administering monetary charitable contributions to fund medical research
Publications
History of USPTO decisions and trademark events.
24 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/27/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2022
PUBO
PUBLISHED FOR OPPOSITION
10/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
09/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
09/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/07/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/03/2022
ALIE
ASSIGNED TO LIE
09/02/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/20/2022
GNRT
NON-FINAL ACTION E-MAILED
01/20/2022
CNRT
NON-FINAL ACTION WRITTEN
01/20/2022
DOCK
ASSIGNED TO EXAMINER
01/12/2022
DOCK
ASSIGNED TO EXAMINER
01/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/04/2021
NWAP
NEW APPLICATION ENTERED
05/04/2021
Continuous trademark protection
Get notified about every new filing that threatens GLIOBLASTOMA FOUNDATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.